Bayer Drug Iberogast Under Investigation -Handelsblatt

--Bayer AG's (BAYN.XE) digestive medication Iberogast is at the center of an investigation by the Cologne public prosecutor's office for a possible connection with the death of a person who took the medication, German business magazine Handelsblatt reports.

--According to the publication, the conglomerate refused to add warnings about possible liver damage and failure to the drug's package leaflet for years.

--The company only added them last year, when it became known that a woman in Germany died of liver failure and interior bleeding who previously took the medication, Handelsblatt reports.

--Bayer wasn't immediately available for comment.

Full story (in German): https://bit.ly/2Y9Sncd

Write to Barcelona editors at barcelonaeditors@dowjones.com

(END) Dow Jones Newswires

July 22, 2019 04:26 ET (08:26 GMT)

Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Mar 2024 to Apr 2024